Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Pliant Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 92 | 2 | 88 | −2 |
| Shares | 31.6M | 23.3K | 30.1M | −1.45M (−4.6%) |
| Value | $222.1M | $164.0K | $241.5M | +$19.5M (+8.8%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 470,601 | $3.77M | 0.16% |
| Great Point Partners LLC | 357,263 | $2.86M | 0.74% |
| Ergoteles LLC | 108,488 | $869.0K | 0.03% |
| Susquehanna International Group, LLP | 49,792 | $399.0K | 0.00% |
| Marshall Wace, LLP | 46,414 | $371.0K | 0.00% |
| Algert Global LLC | 36,020 | $289.0K | 0.02% |
| PDT Partners, LLC | 24,378 | $195.0K | 0.02% |
| Cornercap Investment Counsel Inc | 24,280 | $194.0K | 0.03% |
| Schonfeld Strategic Advisors LLC | 19,100 | $153.0K | 0.00% |
| HSBC Holdings PLC | 18,070 | $144.0K | 0.00% |
| Delphia (USA) Inc. | 17,177 | $138.0K | 0.09% |
| Corton Capital Inc. | 15,747 | $126.0K | 0.12% |
| Belvedere Trading LLC | 6,490 | $125.0K | 0.14% |
| Qube Research & Technologies Ltd | 13,459 | $108.0K | 0.00% |
| Caption Management, LLC | 11,000 | $88.0K | 0.01% |
| Graham Capital Management, L.P. | 10,202 | $81.0K | 0.00% |
| Jefferies Group LLC | 6,799 | $54.5K | 0.00% |
| Cutler Group LP | 900 | $7.00K | 0.00% |
| Massmutual Trust Co FSB | 90 | $1.00K | 0.00% |
| Credit Suisse AG | 13 | $0 | 0.00% |
| Signaturefd, LLC | 59 | $0 | 0.00% |
Sold out (23)
Institutions that held Pliant Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Walleye Capital LLC | 238,255 | $1.67M |
| Ikarian Capital, LLC | 90,805 | $636.0K |
| Nuveen Asset Management, LLC | 81,824 | $619.0K |
| Swiss National Bank | 29,800 | $209.0K |
| Alliancebernstein L.P. | 24,000 | $168.0K |
| Rhumbline Advisers | 22,867 | $160.0K |
| California State Teachers Retirement System | 20,864 | $146.0K |
| UBS Asset Management Americas Inc | 15,199 | $106.5K |
| American International Group, Inc. | 11,944 | $84.0K |
| Manufacturers Life Insurance Company, The | 11,300 | $79.2K |
| Clear Creek Financial Management, LLC | 11,000 | $77.0K |
| Invesco Ltd. | 10,200 | $72.0K |
| Virtus ETF Advisers LLC | 10,224 | $72.0K |
| Nisa Investment Advisors, LLC | 8,000 | $56.0K |
| Legal & General Group Plc | 5,792 | $41.0K |
| Amalgamated Bank | 3,844 | $27.0K |
| STRS Ohio | 3,000 | $21.0K |
| Ameritas Investment Partners, Inc. | 1,954 | $14.0K |
| Point72 Hong Kong Ltd | 804 | $6.00K |
| Great West Life Assurance Co | 665 | $5.00K |
| Parallel Advisors, LLC | 658 | $5.00K |
| Lindbrook Capital, LLC | 224 | $2.00K |
| Private Capital Group, LLC | 197 | $1.00K |
Not filed for Q2 2022 yet (2)
Institutions that held Pliant Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 19,500 | $137.0K |
| Amalgamated Financial Corp. | 3,844 | $27.0K |